FR2315916A2 - Melanges therapeutiques comprenant des analogues alpha hydroxy acides d'acides amines essentiels et leur administration a l'homme en vue de l'amelioration de la synthese proteique et la suppression de la formation d'uree - Google Patents

Melanges therapeutiques comprenant des analogues alpha hydroxy acides d'acides amines essentiels et leur administration a l'homme en vue de l'amelioration de la synthese proteique et la suppression de la formation d'uree

Info

Publication number
FR2315916A2
FR2315916A2 FR7624203A FR7624203A FR2315916A2 FR 2315916 A2 FR2315916 A2 FR 2315916A2 FR 7624203 A FR7624203 A FR 7624203A FR 7624203 A FR7624203 A FR 7624203A FR 2315916 A2 FR2315916 A2 FR 2315916A2
Authority
FR
France
Prior art keywords
suppression
humans
administration
improvement
protein synthesis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7624203A
Other languages
English (en)
Other versions
FR2315916B2 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johns Hopkins University
Original Assignee
Johns Hopkins University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/669,588 external-priority patent/US4100160A/en
Application filed by Johns Hopkins University filed Critical Johns Hopkins University
Publication of FR2315916A2 publication Critical patent/FR2315916A2/fr
Application granted granted Critical
Publication of FR2315916B2 publication Critical patent/FR2315916B2/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR7624203A 1976-03-23 1976-08-06 Melanges therapeutiques comprenant des analogues alpha hydroxy acides d'acides amines essentiels et leur administration a l'homme en vue de l'amelioration de la synthese proteique et la suppression de la formation d'uree Granted FR2315916A2 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/669,588 US4100160A (en) 1974-04-15 1976-03-23 Therapeutic compositions comprising alpha-hydroxy analogs of essential amino acids and their administration to humans for promotion of protein synthesis and suppression of urea formation

Publications (2)

Publication Number Publication Date
FR2315916A2 true FR2315916A2 (fr) 1977-01-28
FR2315916B2 FR2315916B2 (fr) 1979-09-14

Family

ID=24686912

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7624203A Granted FR2315916A2 (fr) 1976-03-23 1976-08-06 Melanges therapeutiques comprenant des analogues alpha hydroxy acides d'acides amines essentiels et leur administration a l'homme en vue de l'amelioration de la synthese proteique et la suppression de la formation d'uree

Country Status (3)

Country Link
DE (1) DE2712777A1 (fr)
FR (1) FR2315916A2 (fr)
GB (1) GB1575646A (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2454434A1 (fr) * 1979-04-18 1980-11-14 Univ Johns Hopkins Sels mixtes d'acides amines essentiels ou semi-essentiels et de produits analogues, exempts d'azote, de ces acides, et leur utilisation dans le traitement de desordres renaux et hepatiques
EP0300878A1 (fr) * 1987-07-23 1989-01-25 Nb International Technologies Compositions pharmaceutiques utiles pour le traitement de l'urémie
FR2695317A1 (fr) * 1992-09-07 1994-03-11 Monal Lab Composition apte à stimuler la sécrétion d'insuline destinée au traitement du diabète non insulino-dépendant.
WO2008122613A2 (fr) * 2007-04-04 2008-10-16 Evonik Degussa Gmbh Complément alimentaire contenant des alpha-céto-acides

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3943424A1 (de) * 1989-12-30 1991-07-04 Nephro Medica Pharma Infusions- und injektionsloesung zur intravenoesen verabreichung
DE10112925A1 (de) * 2001-03-13 2002-10-02 Erich Eigenbrodt Verwendung von Zuckerphosphaten, Zuckerphosphatanalogen, Aminosäuren, Aminosäureanalogen zur Modulation von Transaminasen und/oder der Assoziation p36/Malat Dehydrogenase
US20040152772A1 (en) * 2001-03-13 2004-08-05 Erich Eigenbrodt 1-butyric acid derivatives and the use thereof
DE10112924A1 (de) * 2001-03-13 2002-10-02 Erich Eigenbrodt 1-Butansäurederivate, pharmazeutische Zusammensetzungen enthaltend solche Derivate und Verwendungen solcher Derivate
DE102009016119A1 (de) * 2009-04-03 2010-10-14 Evonik Degussa Gmbh Nahrungsergänzungsmittel enthaltend alpha-Ketosäuren zur Unterstützung der Diabetestherapie

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NEANT *

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2454434A1 (fr) * 1979-04-18 1980-11-14 Univ Johns Hopkins Sels mixtes d'acides amines essentiels ou semi-essentiels et de produits analogues, exempts d'azote, de ces acides, et leur utilisation dans le traitement de desordres renaux et hepatiques
EP0300878A1 (fr) * 1987-07-23 1989-01-25 Nb International Technologies Compositions pharmaceutiques utiles pour le traitement de l'urémie
US4908214A (en) * 1987-07-23 1990-03-13 Synthelabo Pharmaceutical tablet for the treatment of uraemia
FR2695317A1 (fr) * 1992-09-07 1994-03-11 Monal Lab Composition apte à stimuler la sécrétion d'insuline destinée au traitement du diabète non insulino-dépendant.
EP0587476A1 (fr) * 1992-09-07 1994-03-16 Société Civile JOUVENET Compositions renfermant des acide aminé mono ou polyhydroxylé pour le traitement du diabète non insulinodépendant
WO2008122613A2 (fr) * 2007-04-04 2008-10-16 Evonik Degussa Gmbh Complément alimentaire contenant des alpha-céto-acides
WO2008122473A2 (fr) * 2007-04-04 2008-10-16 Evonik Degussa Gmbh Complément alimentaire contenant des acides alpha-céto
WO2008122473A3 (fr) * 2007-04-04 2009-04-23 Evonik Degussa Gmbh Complément alimentaire contenant des acides alpha-céto
WO2008122613A3 (fr) * 2007-04-04 2009-06-04 Evonik Degussa Gmbh Complément alimentaire contenant des alpha-céto-acides
RU2492705C2 (ru) * 2007-04-04 2013-09-20 Эвоник Дегусса Гмбх ПИЩЕВАЯ ДОБАВКА, СОДЕРЖАЩАЯ α-КЕТОКИСЛОТЫ

Also Published As

Publication number Publication date
DE2712777A1 (de) 1977-10-20
FR2315916B2 (fr) 1979-09-14
GB1575646A (en) 1980-09-24

Similar Documents

Publication Publication Date Title
FR2274290A2 (fr) Medicament a base d'alpha-hydroxy-acides analogues d'amino-acides, en association avec des acides alpha-cetoniques analogues d'amino-acides, pour favoriser la synthese des proteines et supprimer la formation de l'uree dans l'organisme
HUP0100815A2 (hu) Neurológiai és neuropszichiátriai rendellenességek kezelésére szolgáló gyógyszerkészítmények
FR2417500A1 (fr) Derives d'amino-acides cycliques dehydrogenes et leur utilisation therapeutique
FR2319338A1 (fr) Nouveaux derives de a- phenyl benzylideniques des acides amines, leur preparation et les medicaments qui en contiennent
IT7851510A0 (it) Ammidi di amminoacidi ciclici loro preparazione e loro applicazione quali medicamenti
IT1127322B (it) Composizioni farmaceutiche con esaltazione dell'attivita' terapeutica di cortisonici
IT1086169B (it) Endoprotesi per le articolazioni dell'apparato motorio umano
FR2315916A2 (fr) Melanges therapeutiques comprenant des analogues alpha hydroxy acides d'acides amines essentiels et leur administration a l'homme en vue de l'amelioration de la synthese proteique et la suppression de la formation d'uree
PT86144A (en) Porocess for the preparation of a protein having similar activity to g-tsf human factor and of pharmaceutical compositions therewith
EP0207011A3 (en) Use of some alkanoyl l-carnitines for the therapeutical treatment of idiopathic and induced parkinsonism
BE857994A (fr) Acides dihydro-oxo-nicotiniques leur preparation et leur application en therapeutique
ZA772514B (en) Improvements relating to the administration of pharmaceutically active substances to animals
BE803567A (fr) Composition et methode destinees a favoriser la synthese des proteines et la suppression de la formation d'uree dans l'organisme
FR2517680B1 (fr) Derives n-(vinblastinoyl-23) d'acides amines, leur preparation et leur application therapeutique
FR2276283A1 (fr) Preparation d'acides carboxyliques, notamment d'a-ceto-acides
BE868590A (fr) Derives alpha-acetyleniques et alpha-vinyliques d'amino-acides
FR2296419A1 (fr) Nouveaux amides peptidiques d'acides ergoline-8-carboxyliques, leur preparation et leur application comme medicaments
BE860162A (fr) Derives actifs de l'uree leur procede de preparation ainsi que les compositions therapeutiques les contenant
IT1068266B (it) Preparazione di 2 amino i alcooli
FR1537901A (fr) Dérivés amidés d'acides halogéno et nitro benzoïques et leur préparation
BE834591A (fr) Synthese d'acides epoxyalkylphosphoniques
FR2275212A1 (fr) Nouveaux amides peptidiques d'acides 6-alkyl-ergoline-8-carboxyliques, leur preparation et leur application comme medicaments
NZ184047A (en) Peptide derivatives of phosohonic and phosphinic acides and pharmaceutical compositions
BE803568A (fr) Composition et methode destinees a favoriser la synthese des proteines et la suppression de la formation d'uree dans l'organisme
FR2285885A1 (fr) Nouveaux amides peptidiques d'acides 6-alkyl-ergoline-8-carboxyliques, leur preparation et leur application comme medicaments